CVS Health Corp [CVS] stock prices are up 0.77% to $78.41 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CVS shares have gain 1.12% over the last week, with a monthly amount drifted -4.98%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CVS Health Corp [NYSE: CVS] stock has seen the most recent analyst activity on October 14, 2025, when Goldman initiated its Buy rating and assigned the stock a price target of $91. Previously, UBS upgraded its rating to Buy on August 18, 2025, and kept the price target unchanged to $79. On August 14, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $82 on the stock. Leerink Partners upgraded its rating to an Outperform and increased its price target to $75 on February 13, 2025. Cantor Fitzgerald upgraded its rating to an Overweight. Edward Jones upgraded its rating to Buy for this stock on January 30, 2025. In a note dated December 03, 2024, Deutsche Bank upgraded a Buy rating on this stock but restated the target price of $66.
The stock price of CVS Health Corp [CVS] has been fluctuating between $43.56 and $85.15 over the past year. Currently, Wall Street analysts expect the stock to reach $91.22 within the next 12 months. CVS Health Corp [NYSE: CVS] shares were valued at $78.41 at the most recent close of the market. An investor can expect a potential return of 16.34% based on the average CVS price forecast.
Analyzing the CVS fundamentals
The CVS Health Corp [NYSE:CVS] reported sales of 393.94B for trailing twelve months, representing a surge of 7.83%. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 77.48 points at the first support level, and at 76.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 79.61, and for the 2nd resistance point, it is at 80.80.
Ratios To Look Out For
It’s worth pointing out that CVS Health Corp [NYSE:CVS]’s Current Ratio is 0.83. In addition, the Quick Ratio stands at 0.63 and the Cash Ratio stands at 0.1. Considering the valuation of this stock, the price to sales ratio is 0.25, the price to book ratio is 1.37 and price to earnings (TTM) ratio is 204.89.
Transactions by insiders
Recent insider trading involved Finucane Anne A., Director, that happened on Aug 20 ’25 when 7500.0 shares were sold. Director, Finucane Anne A. completed a deal on Aug 20 ’25 to buy 7500.0 shares. Meanwhile, Director SANSONE GUY P bought 1570.0 shares on Jun 05 ’25.
